metaanalysi
synthes
current
evid
trial
evalu
associ
steroid
therapi
osteonecrosi
incid
patient
sever
acut
respiratori
syndrom
sar
result
suggest
higher
cumul
dose
longer
treatment
durat
steroid
like
lead
develop
osteonecrosi
sar
patient
introduct
link
steroid
treatment
risk
osteonecrosi
sar
patient
remain
unknown
present
metaanalysi
aim
examin
doserespons
associ
steroid
therapi
osteonecrosi
incid
sar
patient
sex
differ
develop
steroidinduc
osteonecrosi
also
examin
method
search
pubm
web
scienc
cnki
wanfang
studi
involv
steroid
therapi
report
osteonecrosi
data
sar
patient
two
author
independ
extract
data
individu
studi
rate
ratio
rr
osteonecrosi
calcul
use
randomeffect
model
result
ten
studi
recov
sar
patient
met
inclus
criteria
close
relationship
osteonecrosi
incid
cumul
dose
treatment
durat
steroid
observ
summari
rr
osteonecrosi
confid
interv
ci
p
per
g
increas
cumul
dose
steroid
ci
p
increment
increas
treatment
durat
relationship
nonlinear
p
nonlinear
p
nonlinear
signific
differ
risk
develop
osteonecrosi
male
femal
patient
rr
ci
p
conclus
sar
patient
receiv
higher
cumul
dose
longer
treatment
durat
steroid
like
develop
osteonecrosi
sex
differ
dosedepend
side
effect
find
suggest
import
reduc
osteonecrosi
risk
modifi
cumul
dose
treatment
durat
steroid
sar
patient
steroid
commonli
use
immunomodulatori
agent
modul
immun
activ
reduc
inflamm
variou
critic
diseas
howev
sinc
introduct
steroid
treatment
autoimmun
diseas
investig
becom
awar
injuri
effect
abund
literatur
document
steroidrel
osteonecrosi
causal
relationship
well
establish
steroid
use
becom
common
nontraumat
caus
osteonecrosi
preval
rang
outbreak
sever
acut
respiratori
syndrom
sar
caus
approxim
peopl
infect
sarsassoci
coronaviru
sarscov
sarscov
novel
viru
human
be
encount
first
time
effect
antivir
agent
treatment
highdos
steroid
treatment
frequent
prescrib
sever
case
reduc
immun
activ
symptom
wide
use
steroid
result
develop
seriou
side
effect
mani
recov
sar
patient
includ
osteonecrosi
howev
relationship
steroid
therapi
osteonecrosi
remain
unclear
partli
although
number
studi
report
preval
steroidrel
osteonecrosi
recov
patient
fail
address
regimen
use
absenc
inform
regard
steroid
administr
regimen
prevent
research
make
precis
evalu
link
addit
felson
colleagu
report
doserespons
relationship
steroid
use
incid
osteonecrosi
howev
whether
similar
doserespons
relationship
sar
patient
receiv
steroid
remain
unknown
furthermor
wonder
sex
differ
develop
steroidrel
osteonecrosi
sar
patient
therefor
current
metaanalysi
aim
examin
effect
steroid
therapi
osteonecrosi
recov
sar
patient
sex
differ
develop
steroidinduc
osteonecrosi
also
examin
metaanalysi
conduct
accord
prisma
recommend
criteria
report
metaanalysi
guidelin
statist
analysi
method
inclus
criteria
specifi
document
protocol
electron
databas
search
conduct
use
pubm
studi
address
sar
patient
receiv
steroid
therapi
regimen
steroid
treatment
exclud
addit
studi
report
less
three
categori
cumul
dose
treatment
durat
steroid
also
exclud
current
metaanalysi
includ
studi
use
magnet
reson
imag
mri
screen
osteonecrosi
imag
frequent
taken
hip
knee
shoulder
ankl
wrist
osteonecrosi
defin
subchondr
intramedullari
area
demarc
distinct
margin
rim
low
signal
intens
encompass
medullari
fat
imag
two
author
xw
ff
independ
review
extract
data
includ
studi
resolv
disagr
discuss
two
paper
report
similar
data
one
studi
use
final
metaanalysi
discuss
contact
author
addit
inform
necessari
detail
extract
includ
follow
steroid
therapi
regimen
dosag
durat
puls
steroid
therapi
etc
total
number
sar
patient
osteonecrosi
case
respect
proport
women
men
followup
time
mean
median
age
particip
method
osteonecrosi
detect
data
extract
follow
method
provid
cochran
review
handbook
use
rate
ratio
rr
osteonecrosi
outcom
randomeffect
model
use
doserespons
metaanalysi
fixedeffect
model
appli
high
vs
low
analysi
examin
sex
differ
develop
steroidrel
osteonecrosi
studi
report
rr
confid
interv
ci
calcul
use
categori
case
respect
observ
number
patient
compar
refer
categori
includ
studi
report
median
mean
dose
steroid
categori
design
steroid
dosag
categori
also
design
median
mean
day
treatment
categori
treatment
durat
categori
studi
report
rang
steroid
dose
treatment
durat
categori
use
averag
valu
lower
upper
bound
categori
highest
categori
openend
assum
interv
length
adjac
interv
lowest
categori
openend
dose
categori
treatment
durat
categori
assign
averag
valu
upper
bound
zero
first
calcul
summari
rr
ci
highest
vs
lowest
categori
cumul
dose
treatment
durat
steroid
use
fixedeffect
model
propos
dersimonian
laird
doserespons
metaanalysi
perform
use
method
describ
greenland
longneck
studyspecif
slope
linear
trend
ci
calcul
natur
log
rr
ci
across
categori
cumul
dose
treatment
durat
potenti
nonlinear
doserespons
associ
osteonecrosi
cumul
dose
treatment
durat
estim
use
fraction
polynomi
model
cochran
q
test
p
statist
signific
use
determin
betweenstudi
heterogen
funnel
plot
gener
cumul
dose
treatment
durat
steroid
examin
possibl
public
bia
twotail
p
valu
consid
signific
version
stata
softwar
statacorp
lp
colleg
station
tx
usa
use
perform
metaanalysi
produc
graph
test
robust
result
carri
post
hoc
sensit
analysi
explor
possibl
impact
studi
extrem
result
exclud
one
studi
time
two
studi
largest
neg
largest
posit
impact
summari
estim
sensit
analysi
perform
cumul
dose
steroid
also
determin
sex
differ
develop
steroidrel
osteonecrosi
conduct
metaanalysi
men
women
databas
search
identifi
screen
potenti
abstract
exclud
either
unrel
specif
topic
duplic
trial
differ
databas
sixtythre
fulltext
articl
review
elig
studi
exclud
follow
reason
observ
osteonecrosi
steroid
therapi
regimen
abstract
other
includ
studi
report
similar
data
cumul
dose
treatment
durat
categori
report
osteonecrosi
locat
osteonecrosi
case
fig
ten
studi
includ
total
sar
patient
meanmedian
age
year
met
inclus
criteria
enter
final
metaanalysi
patient
develop
osteonecrosi
seven
articl
publish
chines
publish
english
seven
studi
report
number
osteonecrosi
case
male
femal
patient
eight
studi
cohort
nest
casecontrol
patient
china
hong
kong
public
date
rang
inform
regard
patient
studi
list
tabl
characterist
includ
studi
tabl
sar
patient
includ
receiv
steroid
therapi
methylprednisolon
commonli
use
drug
two
studi
report
prednisolon
dose
comput
methylprednisoloneequival
dose
use
convers
factor
one
studi
present
daili
dose
steroid
thu
calcul
cumul
dose
multipli
daili
dose
mean
treatment
durat
mean
cumul
dose
methylprednisolon
rang
g
mean
treatment
durat
rang
day
patient
affect
progress
deterior
frequent
receiv
puls
intraven
nine
studi
includ
highest
vs
lowest
analysi
steroid
doserel
osteonecrosi
electron
supplementari
materi
exclud
one
studi
zero
event
report
refer
categori
pool
rr
osteonecrosi
ci
p
rel
low
level
heterogen
q
p
fig
six
studi
pool
highest
vs
lowest
analysi
treatment
durationrel
osteonecrosi
electron
supplementari
materi
four
studi
remov
analysi
address
durat
treatment
summari
rr
osteonecrosi
ci
p
low
level
betweenstudi
heterogen
q
p
fig
doserespons
metaanalys
incorpor
studi
detect
associ
cumul
dose
treatment
durat
respect
osteonecrosi
two
studi
exclud
estim
relationship
cumul
dose
osteonecrosi
one
studi
report
two
categori
cumul
dose
anoth
zero
event
refer
categori
analysi
associ
treatment
durat
osteonecrosi
studi
exclud
fig
ci
p
increment
treatment
durat
fig
level
heterogen
studi
rel
high
cumul
dose
q
p
treatment
durat
q
p
pronounc
evid
nonlinear
associ
cumul
dose
p
nonlinear
treatment
durat
p
nonlinear
osteonecrosi
subgroup
analysi
seven
studi
conduct
examin
sex
differ
develop
steroidrel
osteonecrosi
find
suggest
male
femal
patient
similar
respons
steroid
therapi
rate
differ
osteonecrosi
approxim
ci
p
level
heterogen
studi
rel
low
q
p
sensit
analysi
suggest
result
consist
exclud
studi
either
largest
posit
impact
largest
neg
impact
summari
estim
remov
studi
largest
posit
impact
summari
rr
osteonecrosi
ci
p
increment
total
dose
steroid
repeat
analysi
exclud
studi
largest
neg
impact
summari
rr
osteonecrosi
ci
p
per
g
increas
cumul
dose
visual
inspect
funnel
plot
cumul
dose
electron
supplementari
materi
treatment
durat
electron
supplementari
materi
suggest
slight
asymmetri
like
heterogen
studi
contribut
asymmetri
sever
data
point
outsid
confid
limit
furthermor
examin
heterogen
studi
suggest
summari
estim
cumul
dose
treatment
durat
heterogen
metaanalysi
provid
quantit
evid
relationship
steroid
administr
osteonecrosi
incid
sar
patient
find
indic
relationship
osteonecrosi
incid
cumul
dose
treatment
durat
steroid
nonlinear
subgroup
analysi
reveal
sex
differ
develop
steroidinduc
osteonecrosi
male
femal
patient
although
side
effect
report
past
decad
sarsrecov
patient
receiv
steroid
therapi
clear
link
steroid
administr
osteonecrosi
incid
previous
unclear
studi
demonstr
first
time
cumul
dose
treatment
durat
steroid
close
associ
occurr
osteonecrosi
recov
sar
patient
nonlinear
relationship
observ
cumul
dose
osteonecrosi
nonlinear
regress
fig
suggest
risk
osteonecrosi
remain
rela
v
e
l
l
w
w
h
e
n
h
e
l
e
f
e
r
methylprednisolon
g
howev
incid
osteonecrosi
increas
total
dose
increas
g
seem
reach
highest
risk
total
dose
approxim
g
find
suggest
lower
cumul
dose
steroid
methylprednisolon
g
rel
safe
sar
patient
physician
avoid
use
high
dose
steroid
especi
cumul
dose
g
close
relationship
total
steroid
dose
osteonecrosi
incid
diseas
well
establish
followup
studi
nakamura
colleagu
report
approxim
system
lupu
erythematosu
sle
patient
requir
increas
steroid
dose
develop
osteonecrosi
shibatani
colleagu
evalu
renaltranspl
recipi
underw
multipl
reject
cycl
demonstr
close
relationship
p
osteonecrosi
cumul
steroid
dose
felson
colleagu
report
liner
doserespons
relationship
steroid
usag
osteonecrosi
incid
show
increas
risk
osteonecrosi
everi
mgday
increas
oral
steroid
first
month
therapi
difficult
distinguish
effect
total
dose
mean
daili
dose
steroid
osteonecrosi
patient
receiv
higher
cumul
dose
usual
also
receiv
higher
mean
daili
dose
exampl
averag
total
dose
steroid
taken
sar
patient
metaanalysi
approxim
g
meant
receiv
mean
daili
dose
mg
summarili
find
suggest
cumul
dose
steroid
strong
predictor
risk
osteonecrosi
sar
patient
observ
nonlinear
relationship
treatment
durat
steroid
osteonecrosi
incid
suggest
treatment
durat
import
risk
factor
develop
osteonecrosi
find
consist
nakamura
studi
demonstr
progress
osteonecrosi
associ
higher
dose
steroid
treatment
longer
durat
work
provid
import
inform
concern
link
nonlinear
regress
fig
indic
treatment
durat
day
remain
safe
sar
patient
rr
osteonecrosi
approxim
osteonecrosi
risk
increas
increas
treatment
durat
day
appear
reach
highest
risk
approxim
day
find
clinic
import
differ
steroid
treatment
durat
associ
differ
level
risk
develop
osteonecrosi
previous
unknown
whether
incid
steroidrel
osteonecrosi
higher
femal
sar
patient
male
patient
find
reveal
femal
male
sar
patient
similar
incid
steroidrel
osteonecrosi
result
provid
pool
evid
demonstr
women
like
develop
steroidinduc
osteonecrosi
men
occurr
osteonecrosi
observ
earli
month
highdos
steroid
usag
sar
patient
sever
studi
detect
high
incid
osteonecrosi
within
half
year
contrast
mean
time
occurr
osteonecrosi
renaltranspl
cohort
includ
felson
review
rang
month
onset
osteonecrosi
patient
sle
often
occur
later
mean
time
initi
steroid
treatment
occurr
osteonecrosi
year
differ
length
time
develop
osteonecrosi
might
due
high
dose
steroid
use
sar
patient
averag
total
dose
g
mean
treatment
period
day
addit
discrep
studi
might
also
due
recent
increas
use
mri
diagnosi
earlystag
osteonecrosi
may
otherwis
undetect
radiograph
assess
saito
et
al
report
osteonecrosi
close
associ
total
steroid
dose
detect
occurr
osteonecrosi
within
week
renaltranspl
surgeri
argu
mri
high
sensit
specif
diagnosi
osteonecrosi
compar
radiograph
examin
therefor
highdos
steroid
usag
mri
use
probabl
contribut
earlier
detect
osteonecrosi
sar
patient
sensit
analysi
show
result
studi
robust
exclud
studi
extrem
outcom
howev
heterogen
studi
rel
high
cumul
dose
treatment
durat
steroid
studi
limit
total
number
sar
patient
approxim
patient
die
sar
outbreak
howev
oneseventh
patient
followup
mri
examin
administ
steroid
therapi
regimen
constitut
major
limit
number
particip
depend
mainli
respons
sar
patient
followup
visit
individu
studi
small
sampl
size
might
pose
risk
bia
addit
detect
bia
might
exist
receiv
higher
dose
may
like
undergo
test
metaanalysi
pool
data
recov
sar
patient
determin
whether
steroid
dose
treatment
durat
associ
osteonecrosi
find
provid
obviou
evid
nonlinear
relationship
osteonecrosi
cumul
dose
treatment
durat
steroid
nonlinear
regress
indic
steroid
therapi
cumul
dose
methylprednisolon
g
treatment
durat
day
result
rel
low
risk
develop
osteonecrosi
subgroup
analysi
demonstr
sex
differ
develop
steroidinduc
osteonecrosi
male
femal
patient
summarili
present
find
indic
cumul
dose
treatment
durat
steroid
import
risk
factor
develop
osteonecrosi
sar
patient
